Trial Profile
A Phase II Trial of O6-Benzylguanine [benzylguanine] (NSC 637037) and BCNU (Carmustine) in Patients With Advanced Soft Tissue Sarcoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Jul 2015
Price :
$35
*
At a glance
- Drugs Benzylguanine (Primary) ; Carmustine polifeprosan 20 wafer (Primary)
- Indications Sarcoma
- Focus Therapeutic Use
- 10 Sep 2005 New trial record.